Michael I. D’angelica
#134,213
Most Influential Person Now
Michael I. D’angelica's AcademicInfluence.com Rankings
Michael I. D’angelicamedical Degrees
Medical
#2295
World Rank
#2710
Historical Rank
Oncology
#134
World Rank
#138
Historical Rank

Michael I. D’angelicaphilosophy Degrees
Philosophy
#6689
World Rank
#9770
Historical Rank
Logic
#3817
World Rank
#5029
Historical Rank

Download Badge
Medical Philosophy
Why Is Michael I. D’angelica Influential?
(Suggest an Edit or Addition)Michael I. D’angelica's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- NCCN clinical practice guidelines in oncology: hepatobiliary cancers. (2009) (2154)
- The International Position on Laparoscopic Liver Surgery: The Louisville Statement, 2008 (2009) (1353)
- Actual 10-year survival after resection of colorectal liver metastases defines cure. (2007) (1031)
- CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. (2008) (959)
- Intrahepatic Cholangiocarcinoma: Rising Frequency, Improved Survival, and Determinants of Outcome After Resection (2008) (690)
- Patterns of Initial Recurrence in Completely Resected Gastric Adenocarcinoma (2004) (542)
- Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection (2003) (462)
- Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. (2010) (452)
- Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma (2003) (414)
- Gallbladder cancer (GBC): 10‐year experience at Memorial Sloan‐Kettering Cancer Centre (MSKCC) (2008) (385)
- Operative Blood Loss Independently Predicts Recurrence and Survival After Resection of Hepatocellular Carcinoma (2009) (357)
- Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Analysis of Clinicopathologic Features and Outcome (2004) (342)
- Pasireotide for postoperative pancreatic fistula. (2014) (335)
- The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. (2006) (315)
- Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies (2018) (312)
- Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions (2014) (306)
- Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades (2011) (297)
- Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention (2018) (272)
- Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone. (2016) (260)
- Comparative genomic analysis of primary versus metastatic colorectal carcinomas. (2012) (257)
- Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. (2021) (257)
- Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center. (2016) (252)
- 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. (2008) (244)
- Ablation of perivascular hepatic malignant tumors with irreversible electroporation. (2012) (236)
- The Impact of Margins on Outcome After Hepatic Resection for Colorectal Metastasis (2007) (229)
- Increased Use of Parenchymal-Sparing Surgery for Bilateral Liver Metastases From Colorectal Cancer Is Associated With Improved Mortality Without Change in Oncologic Outcome: Trends in Treatment Over Time in 440 Patients (2008) (228)
- The Miami International Evidence-Based Guidelines on Minimally Invasive Pancreas Resection. (2019) (218)
- Effect of Postoperative Morbidity on Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer (2008) (217)
- Intraductal papillary neoplasm of the bile duct: A biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? (2012) (216)
- NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. (2017) (211)
- A Selective Approach to the Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive Patients (2006) (206)
- Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. (2011) (205)
- Outcome of patients with fibrolamellar hepatocellular carcinoma (2006) (200)
- Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. (2009) (200)
- Liver Cell Adenoma: A Multicenter Analysis of Risk Factors for Rupture and Malignancy (2009) (199)
- Partial Hepatectomy for Metastases From Noncolorectal, Nonneuroendocrine Carcinoma (2005) (194)
- Analysis of the Extent of Resection for Adenocarcinoma of the Gallbladder (2009) (194)
- Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. (2005) (191)
- Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. (2007) (187)
- The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. (2012) (180)
- Laparoscopic distal pancreatectomy: evolution of a technique at a single institution. (2010) (175)
- Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic Cancer (2007) (175)
- Combined Portal Vein Embolization and Neoadjuvant Chemotherapy As a Treatment Strategy for Resectable Hepatic Colorectal Metastases (2008) (175)
- Distal pancreatectomy: a single institution's experience in open, laparoscopic, and robotic approaches. (2015) (174)
- Lack of Evidence for Increased Operative Morbidity After Hepatectomy with Perioperative Use of Bevacizumab: A Matched Case-Control Study (2007) (172)
- Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy (2010) (171)
- Accurate Staging for Gallbladder Cancer: Implications for Surgical Therapy and Pathological Assessment (2011) (171)
- Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma (2008) (170)
- Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelines (2017) (169)
- Papillary Phenotype Confers Improved Survival After Resection of Hilar Cholangiocarcinoma (2005) (169)
- BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer (2014) (167)
- Solid Pseudopapillary Tumors of the Pancreas. Clinical Features, Surgical Outcomes, and Long-Term Survival in 45 Consecutive Patients from a Single Center (2011) (165)
- A Nomogram for Predicting Disease-specific Survival After Hepatic Resection for Metastatic Colorectal Cancer (2008) (164)
- Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis. (2014) (164)
- Management of primary liver sarcomas (2007) (163)
- Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. (2007) (156)
- Outcome After Hepatectomy for Multiple (Four or More) Colorectal Metastases in the Era of Effective Chemotherapy (2007) (155)
- Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control. (2017) (154)
- Effect on Outcome of Recurrence Patterns After Hepatectomy for Colorectal Metastases (2011) (154)
- Urgent need for a new staging system in advanced colorectal cancer. (2008) (151)
- A Retrospective Comparison of Microwave Ablation vs. Radiofrequency Ablation for Colorectal Cancer Hepatic Metastases (2014) (149)
- Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant. (2016) (148)
- Operative Drainage Following Pancreatic Resection: Analysis of 1122 Patients Resected Over 5 Years at a Single Institution (2013) (144)
- The Role of Staging Laparoscopy in Hepatobiliary Malignancy: Prospective Analysis of 401 Cases (2003) (144)
- Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. (2009) (140)
- Guidelines Insights: Hepatobiliary Cancers, Version 2.2019. (2019) (140)
- Liver Resection for Metastatic Colorectal Cancer in Patients with Concurrent Extrahepatic Disease: Results in 127 Patients Treated at a Single Center (2009) (138)
- Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. (2007) (137)
- Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. (2009) (137)
- Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case–Control Study (2016) (135)
- Regulatory T Cell Infiltration Predicts Outcome Following Resection of Colorectal Cancer Liver Metastases (2013) (132)
- FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma (2015) (131)
- Hepatic Parenchymal Preservation Surgery: Decreasing Morbidity and Mortality Rates in 4,152 Resections for Malignancy (2014) (130)
- Rates and Patterns of Recurrence for Percutaneous Radiofrequency Ablation and Open Wedge Resection for Solitary Colorectal Liver Metastasis (2007) (129)
- Adequate Lymph Node Assessment for Extrahepatic Bile Duct Adenocarcinoma (2010) (129)
- KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases (2014) (126)
- Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma (2005) (124)
- A Prospective Randomized Trial of Acute Normovolemic Hemodilution Compared to Standard Intraoperative Management in Patients Undergoing Major Hepatic Resection (2008) (123)
- Laparoscopic versus Open Liver Resection: A Matched-Pair Case Control Study (2009) (122)
- A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma (2014) (122)
- A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. (2008) (120)
- T Cell Infiltrate Predicts Long-Term Survival Following Resection of Colorectal Cancer Liver Metastases (2009) (120)
- Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients (2003) (117)
- Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone (2016) (117)
- Actual 10‐year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? (2018) (116)
- Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. (2015) (113)
- Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. (2005) (113)
- Clinical Significance of Intraoperative Bile Duct Margin Assessment for Hilar Cholangiocarcinoma (2008) (113)
- A Matched Case-Control Study of Preoperative Biliary Drainage in Patients with Pancreatic Adenocarcinoma: Routine Drainage Is Not Justified (2009) (109)
- Invasive Carcinoma Arising in Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Matched Control Study with Conventional Pancreatic Ductal Adenocarcinoma (2011) (105)
- Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. (2008) (105)
- Relationship Between Intraoperative Fluid Administration and Perioperative Outcome After Pancreaticoduodenectomy: Results of a Prospective Randomized Trial of Acute Normovolemic Hemodilution Compared With Standard Intraoperative Management (2010) (103)
- Liver Resection for Metastatic Colorectal Cancer in the Presence of Extrahepatic Disease (2009) (103)
- Surgical treatment of hepatocellular carcinoma: expert consensus statement. (2010) (103)
- Comparison of Adjuvant Systemic Chemotherapy With or Without Hepatic Arterial Infusional Chemotherapy After Hepatic Resection for Metastatic Colorectal Cancer (2011) (101)
- Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. (2011) (101)
- Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. (1997) (99)
- Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. (2011) (99)
- A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers (2012) (99)
- Perihepatic Lymph Node Assessment in Patients Undergoing Partial Hepatectomy for Malignancy (2006) (98)
- Laparoscopic Adrenalectomy for Isolated Adrenal Metastasis (2007) (98)
- Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation (2013) (97)
- Polypoid lesions of the gallbladder: diagnosis and followup. (2009) (97)
- NCCN Guidelines Insights: Hepatobiliary Cancers, Version 2.2019: Featured Updates to the NCCN Guidelines (2019) (96)
- CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. (2011) (96)
- Pancreatic Cyst Fluid and Serum Mucin Levels Predict Dysplasia in Intraductal Papillary Mucinous Neoplasms of the Pancreas (2010) (95)
- Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis. (2017) (92)
- Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. (2015) (92)
- Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. (2013) (91)
- Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models. (2016) (91)
- Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. (2015) (90)
- Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection (2016) (90)
- Contemporary experience with postpancreatectomy hemorrhage: results of 1,122 patients resected between 2006 and 2011. (2012) (88)
- Hepatobiliary cancers, version 2.2014. (2014) (88)
- Response to Neoadjuvant Chemotherapy Does Not Predict Overall Survival for Patients With Synchronous Colorectal Hepatic Metastases (2009) (88)
- Robotic Liver Resection: A Case-Matched Comparison (2016) (88)
- Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. (2009) (87)
- Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. (2004) (87)
- Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. (2005) (86)
- Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. (2019) (86)
- Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis (2018) (85)
- Preoperative radiographic assessment of hepatic steatosis with histologic correlation. (2008) (85)
- Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium (2018) (85)
- Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. (2013) (84)
- Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms (2008) (83)
- Is Port Site Resection Necessary in the Surgical Management of Gallbladder Cancer? (2012) (83)
- Predicting the Risk of Perioperative Transfusion for Patients Undergoing Elective Hepatectomy (2009) (83)
- Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases (2018) (82)
- Single-incision laparoscopic liver resection (2011) (82)
- Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. (2014) (79)
- Predicting Dysplasia and Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Development of a Preoperative Nomogram (2013) (79)
- Biliary Self-Expandable Metal Stents Do Not Adversely Affect Pancreaticoduodenectomy (2013) (79)
- Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients (2016) (78)
- Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience. (2013) (77)
- Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy. (2013) (74)
- Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization. (2017) (74)
- Electronic synoptic operative reporting: assessing the reliability and completeness of synoptic reports for pancreatic resection. (2010) (74)
- Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract (2009) (74)
- Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer. (2007) (74)
- Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma (2017) (74)
- Prospective Study of Outcomes after Percutaneous Biliary Drainage for Malignant Biliary Obstruction (2010) (73)
- Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection (2015) (73)
- The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas (2006) (73)
- T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases. (2010) (72)
- Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. (2005) (72)
- Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response (2011) (72)
- Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients. (2018) (70)
- Endoscopic ultrasound-guided transmural drainage of postoperative pancreatic collections. (2014) (70)
- Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. (2016) (70)
- The role of laparoscopic staging in patients with incidental gallbladder cancer. (2011) (69)
- Failure Patterns in Resected Pancreas Adenocarcinoma: Lack of Predicted Benefit to SMAD4 Expression (2013) (69)
- The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer (2018) (68)
- Synchronous Resection of Primary and Liver Metastases for Neuroendocrine Tumors (2012) (67)
- Combined Ablation and Resection (CARe) as an Effective Parenchymal Sparing Treatment for Extensive Colorectal Liver Metastases (2014) (67)
- Caudate hepatectomy for cancer: a single institution experience with 150 patients. (2005) (67)
- Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas. (2007) (66)
- Management of peripancreatic fluid collections following partial pancreatectomy: a comparison of percutaneous versus EUS-guided drainage (2013) (66)
- Pathologic Grade and Tumor Size are Associated with Recurrence-Free Survival in Patients with Duodenal Neuroendocrine Tumors (2014) (65)
- Profile of Plasma Angiogenic Factors Before and After Hepatectomy for Colorectal Cancer Liver Metastases (2006) (64)
- Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? (2005) (64)
- Updated long‐term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy (2016) (64)
- Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. (2006) (63)
- Liver metastases (2021) (61)
- Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models. (2015) (61)
- Biliary Sclerosis after Hepatic Arterial Infusion Pump Chemotherapy for Patients with Colorectal Cancer Liver Metastasis: Incidence, Clinical Features, and Risk Factors (2012) (60)
- Surgical management of hepatic metastases of colorectal cancer. (2015) (60)
- Liver planning software accurately predicts postoperative liver volume and measures early regeneration. (2014) (59)
- Resection of Adrenocortical Carcinoma Liver Metastasis: Is it Justified? (2012) (59)
- Role of Hepatic Artery Infusion Chemotherapy in Treatment of Initially Unresectable Colorectal Liver Metastases: A Review. (2019) (59)
- Differential diagnosis of proximal biliary obstruction. (2006) (59)
- Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. (2014) (59)
- Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement. (2013) (58)
- Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer. (2003) (58)
- Pathologic Response to Preoperative Chemotherapy in Colorectal Liver Metastases: Fibrosis, not Necrosis, Predicts Outcome (2012) (58)
- Goal-Directed Fluid Therapy Using Stroke Volume Variation for Resuscitation after Low Central Venous Pressure-Assisted Liver Resection: A Randomized Clinical Trial. (2015) (58)
- Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results (2011) (58)
- Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome (2017) (58)
- Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort (2017) (55)
- Optimal Abdominal Incision for Partial Hepatectomy: Increased Late Complications with Mercedes-type Incisions Compared to Extended Right Subcostal Incisions (2006) (54)
- The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis. (2012) (53)
- Spatial and phenotypic immune profiling of metastatic colon cancer. (2018) (53)
- Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer. (2010) (53)
- Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. (2013) (53)
- Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases (2013) (53)
- Predicting recurrence patterns after resection of hepatocellular cancer. (2014) (52)
- Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma (2017) (52)
- Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. (2017) (51)
- Hepatic resection for colorectal metastases (2014) (51)
- Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma (2016) (51)
- Comparison Between Perioperative and Postoperative Chemotherapy After Potentially Curative Hepatic Resection for Metastatic Colorectal Cancer (2013) (50)
- Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer (2019) (50)
- Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor (2016) (49)
- Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer. (2018) (49)
- Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer. (2003) (49)
- Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer. (2009) (48)
- Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis. (2013) (48)
- Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease (2011) (48)
- Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential (2018) (48)
- Impact of Obesity and Body Fat Distribution on Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma (2012) (48)
- Simple measurement of intra-abdominal fat for abdominal surgery outcome prediction. (2010) (47)
- CXCR4 Expression Predicts Patient Outcome and Recurrence Patterns after Hepatic Resection for Colorectal Liver Metastases (2012) (46)
- Initial experience with hand-assisted laparoscopic distal pancreatectomy (2005) (46)
- Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma (2021) (45)
- Cytokine-secreting herpes viral mutants effectively treat tumor in a murine metastatic colorectal liver model by oncolytic and T-cell-dependent mechanisms (2007) (45)
- Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. (2015) (45)
- Tumor MHC Class I Expression Improves the Prognostic Value of T-cell Density in Resected Colorectal Liver Metastases (2014) (45)
- Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. (2008) (44)
- Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance (2011) (44)
- American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions. (2014) (44)
- Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer (2017) (44)
- Readmission After Pancreatic Resection: Causes and Causality Pattern (2014) (44)
- Prospective Randomized Controlled Trial of Liberal Vs Restricted Perioperative Fluid Management in Patients Undergoing Pancreatectomy (2016) (44)
- Meeting the biologic challenge of colorectal metastases (2012) (43)
- Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage (2015) (43)
- Patterns of Recurrence After Ablation of Colorectal Cancer Liver Metastases (2012) (43)
- Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes (2015) (43)
- Detailed Pathologic Characteristics of the Primary Colorectal Tumor Independently Predict Outcome after Hepatectomy for Metastases (2012) (43)
- Isolated Hepatic Splenosis: First Reported Case (1998) (43)
- Role of intra‐arterial hepatic chemotherapy in the treatment of colorectal cancer metastases (2010) (43)
- Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance?: Results of 3024 Patients Evaluated at a Single Institution (2017) (43)
- Hepatic Pedicle Clamping During Hepatic Resection for Colorectal Liver Metastases: No Impact on Survival or Hepatic Recurrence (2012) (42)
- Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases (2015) (42)
- The use of imaging in the diagnosis and staging of hepatobiliary malignancies. (2007) (42)
- Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. (2009) (42)
- Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons: A Throw of the Dice? (2020) (41)
- Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon. (1997) (41)
- Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease (2015) (41)
- Renal function after low central venous pressure-assisted liver resection: assessment of 2116 cases. (2015) (40)
- Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes. (2015) (39)
- Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution (2013) (38)
- Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies (2016) (38)
- Treatment of liver colorectal metastases: Role of laparoscopy, radiofrequency ablation, and microwave coagulation (2010) (38)
- Synchronous Hepatic Metastases from Colon Cancer: Changing Treatment Strategies and Results of Surgical Intervention (2009) (38)
- Positive Postoperative CEA is a Strong Predictor of Recurrence for Patients After Resection for Colorectal Liver Metastases (2015) (37)
- Perihepatic Lymph Node Micrometastases Impact Outcome after Partial Hepatectomy for Colorectal Metastases (2008) (36)
- Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas (2017) (36)
- The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial (2017) (36)
- Anastomotic Leak Following Low Anterior Resection in Stage IV Rectal Cancer is Associated with Poor Survival (2013) (36)
- Floxuridine Hepatic Arterial Infusion Associated Biliary Toxicity Is Increased by Concurrent Administration of Systemic Bevacizumab (2014) (36)
- A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases (2016) (35)
- Health-Related Quality of Life After Pancreatectomy: Results From a Randomized Controlled Trial (2016) (35)
- Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis. (2013) (35)
- Changes in the management of benign liver tumours: an analysis of 285 patients. (2013) (34)
- Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases (2017) (34)
- Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors (2019) (34)
- Resectable Hilar Cholangiocarcinoma: Surgical Treatment and Long-Term Outcome (2004) (34)
- Impact of pre-operative positron emission tomography in gallbladder cancer. (2014) (34)
- Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis. (2019) (33)
- Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. (2012) (33)
- Regional Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Potential Role for Dynamic Magnetic Resonance Imaging as an Imaging Biomarker and a Survival Update from Two Prospective Clinical Trials (2014) (33)
- Factors Associated With Local Tumor Control and Complications After Thermal Ablation of Colorectal Cancer Liver Metastases: A 15-year Retrospective Cohort Study. (2020) (33)
- Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer (2012) (33)
- CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma (2019) (32)
- Kinetics of liver volume changes in the first year after portal vein embolization. (2010) (32)
- Clinical Features and Outcome of Primary Pancreatic Lymphoma (2015) (32)
- Regional differences in gallbladder cancer pathogenesis: Insights from a multi‐institutional comparison of tumor mutations (2018) (31)
- Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases (2008) (31)
- Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma. (2020) (31)
- Surgeon-patient communication in the treatment of pancreatic cancer. (1998) (30)
- Recurrence patterns following irreversible electroporation for hepatic malignancies (2017) (30)
- Management and extent of resection for intrahepatic cholangiocarcinoma. (2009) (30)
- Incidentally Discovered Pancreatic Intraepithelial Neoplasia: What Is Its Clinical Significance? (2013) (29)
- Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation. (2016) (29)
- Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer. (2014) (29)
- Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection. (2017) (29)
- Genetic Evidence That Intratumoral T-cell Proliferation and Activation Are Associated with Recurrence and Survival in Patients with Resected Colorectal Liver Metastases (2015) (29)
- Gene Expression Profiles Accurately Predict Outcome Following Liver Resection in Patients with Metastatic Colorectal Cancer (2013) (29)
- Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. (2016) (28)
- Treatment of Extensive Metastatic Colorectal Cancer to the Liver with Systemic and Hepatic Arterial Infusion Chemotherapy and Two-Stage Hepatic Resection: The Role of Salvage Therapy for Recurrent Disease (2014) (28)
- Selective use of diagnostic laparoscopy prior to planned hepatectomy for patients with hepatocellular carcinoma. (2004) (28)
- Program and candidate experience with virtual interviews for the 2020 Complex General Surgical Oncology interview season during the COVID pandemic. (2020) (27)
- Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation (2015) (27)
- Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer (2019) (27)
- Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing (2018) (27)
- Pitfalls in avoiding operation for autoimmune pancreatitis. (2011) (25)
- Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer. (2006) (25)
- Surgical management of biliary tract cancers. (2016) (25)
- Timing of elective surgery as a perioperative outcome variable: analysis of pancreaticoduodenectomy. (2014) (25)
- Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN) (2018) (24)
- Laparoscopic Liver Resection Difficulty Score—a Validation Study (2018) (23)
- Extrahepatic bile duct carcinoid tumors: malignant biliary obstruction with a good prognosis. (2007) (22)
- Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative procedures and in-hospital days? (2012) (22)
- A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients (2016) (22)
- Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial (2019) (21)
- Operative morbidity and survival following hepatectomy for colorectal liver metastasis in octogenarians: a contemporary case matched series. (2016) (21)
- Hepatic Arterial Nodal Metastases in Pancreatic Cancer: Is This the Node of Importance? (2013) (21)
- Hepatic resection, hepatic arterial infusion pump therapy, and genetic biomarkers in the management of hepatic metastases from colorectal cancer. (2015) (21)
- Staging laparoscopy for potentially resectable noncolorectal, nonneuroendocrine liver metastases (2002) (20)
- Herpes Simplex Virus (HSV)-Mediated ICAM-1 Gene Transfer Abrogates Tumorigenicity and Induces Anti-Tumor Immunity (1999) (20)
- Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies (2017) (20)
- Outcomes of the Memorial Sloan Kettering Cancer Center International General Surgical Oncology Fellowship. (2016) (20)
- Pharmacologic Prophylaxis, Postoperative INR, and Risk of Venous Thromboembolism after Hepatectomy (2014) (20)
- Liver resection and ablation for metastatic melanoma: A single center experience (2015) (20)
- MicroRNA-203 predicts human survival after resection of colorectal liver metastasis (2016) (20)
- The effects of hepatic cryosurgery on tumor growth in the liver. (1998) (20)
- Cystic lesions of the pancreas: Selection criteria for operative and non-operative management in 209 patients (2003) (20)
- Outcomes after Pancreatectomy with Routine Pasireotide Use. (2019) (19)
- In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors (1999) (19)
- Adrenal Metastasectomy in the Presence and Absence of Extraadrenal Metastatic Disease. (2019) (19)
- Central hepatectomy versus extended hepatectomy for liver malignancy: a matched cohort comparison. (2015) (19)
- Surgical Management of Hepatobiliary and Pancreatic Disorders (2003) (19)
- Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study (2021) (18)
- High-grade dysplasia of the cystic duct margin in the absence of malignancy after cholecystectomy. (2011) (18)
- A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 years (2009) (18)
- Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. (2013) (18)
- A Survey of the Complex General Surgical Oncology Fellowship Programs Regarding Applicant Selection and Rank (2019) (18)
- Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance ? luated at a Single Institution Results of 3024 Patients (2017) (18)
- Laparoscopic staging for liver, biliary, pancreas, and gastric cancer. (2007) (17)
- Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases (2019) (17)
- Histopathological growth patterns and positive margins after resection of colorectal liver metastases. (2018) (17)
- Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection (2021) (17)
- Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. (2019) (16)
- The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma. (2017) (16)
- Mathematical Modeling of the Metastatic Colorectal Cancer Microenvironment Defines the Importance of Cytotoxic Lymphocyte Infiltration and Presence of PD-L1 on Antigen Presenting Cells (2019) (16)
- Anatomy of Hepatic Resectional Surgery. (2016) (16)
- Hepatic arterial infusional chemotherapy in the management of colorectal cancer liver metastases. (2015) (16)
- Comparative Analysis of Outcome in Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria Treated With Liver Transplantation Versus Partial Hepatectomy (2011) (16)
- c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival. (2013) (16)
- Liver resection after hepatic arterial infusion (HAI) plus systemic oxaliplatin (Oxal) combinations in pretreated patients with extensive unresectable colorectal liver metastases (2004) (16)
- Autologous Versus Allogeneic Transfusions: No Difference in Perioperative Outcome After Partial Hepatectomy (2007) (16)
- Efficient cotransduction of tumors by multiple herpes simplex vectors: Implications for tumor vaccine production (2000) (15)
- Hepatic artery infusion pumps (2020) (15)
- Angiographic identification of extrahepatic perfusion after hepatic arterial pump placement: implications for surgical prevention. (2014) (15)
- Early trends in serum phosphate and creatinine levels are associated with mortality following major hepatectomy. (2015) (14)
- Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide Phosphoribosyltransferase. (2017) (14)
- Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights (2022) (14)
- Hospital readmissions after liver surgery for metastatic colorectal cancer. (2015) (14)
- Robotic hepatic arterial infusion pump placement. (2017) (14)
- Spatial mapping of the collagen distribution in human and mouse tissues by force volume atomic force microscopy (2020) (13)
- Uncinate Duct Dilation in Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Radiographic Finding with Potentially Increased Malignant Potential (2014) (13)
- Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma. (2022) (13)
- Patient selection for hepatic resection for metastatic colorectal cancer. (2012) (13)
- 3D image guidance assisted identification of colorectal cancer liver metastases not seen on intraoperative ultrasound: results from a prospective trial. (2017) (13)
- Selecting patients for acute normovolemic hemodilution during hepatic resection: a prospective randomized evaluation of nomogram-based allocation. (2013) (13)
- Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study. (2019) (13)
- Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection. (2019) (13)
- The accuracy of pre-operative imaging in the management of hepatic cysts. (2015) (13)
- Radiation segmentectomy of hepatic metastases with Y-90 glass microspheres (2021) (12)
- Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma (2021) (12)
- Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach? (2019) (12)
- Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis (2018) (12)
- Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer (2016) (12)
- The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma (2016) (12)
- Gallbladder Cancer: Managing the Incidental Diagnosis. (2019) (12)
- HPB Surgery: The Specialty is Here to Stay, but the Training is in Evolution (2016) (12)
- Treatment sequencing for simultaneous colorectal liver metastases (2019) (12)
- Regional Differences in Gallbladder Cancer Pathogenesis: Insights from a Comparison of Cell Cycle-Regulatory, PI3K, and Pro-Angiogenic Protein Expression (2013) (11)
- Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer (2020) (11)
- Risk of Occult Irresectable Disease at Liver Resection for Hepatic Colorectal Cancer Metastases: A Contemporary Analysis (2013) (11)
- Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease (2015) (11)
- A perioperative multidisciplinary care bundle reduces surgical site infections in patients undergoing synchronous colorectal and liver resection. (2019) (11)
- Recurrence Patterns of Intraductal Papillary Mucinous Neoplasms of the Pancreas on Enhanced Computed Tomography (2009) (11)
- Survey of Surgical Oncology Fellowship Graduates 2005–2016: Insight into Initial Practice (2019) (11)
- Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution. (2019) (11)
- Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease (2012) (10)
- Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases (2021) (10)
- Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study (2020) (10)
- Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases. (2022) (10)
- Resection of perihilar biliary schwannoma. (2011) (10)
- Use of Intraoperative Ablation as an Adjunct to Surgical Resection in the Treatment of Recurrent Colorectal Liver Metastases (2011) (10)
- Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery Chemotherapy (2020) (10)
- En bloc resection of diaphragm with lung for recurrent ovarian cancer: a case report. (2006) (10)
- A Call for Caution in Overinterpreting Exceptional Outcomes Following Radical Surgery for Pancreatic Cancer: Let the Data Speak. (2020) (10)
- A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma (2018) (10)
- The Randomized Registry Trial: Two Birds, One Stone. (2017) (10)
- Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis. (2022) (9)
- Intrahepatic and Extrahepatic Biliary Cancer (2007) (9)
- Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases (2018) (9)
- A quantitative assessment of liver metabolites during jaundice using three dimensional phosphorus chemical shift imaging. (2000) (9)
- Unexpected increased biliary toxicity when systemic bevacizumab is added to hepatic arterial infusion. (2010) (9)
- Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging. (2018) (9)
- Extending the Limits of Resection for Colorectal Liver Metastases: Positive Resection Margin and Outcome After Resection of Colorectal Cancer Liver Metastases (2016) (9)
- Treatment patterns and survival in patients with early‐onset pancreatic cancer (2021) (9)
- Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1H MRS study (2013) (8)
- Liver transplantation for colorectal liver metastasis (2019) (8)
- Assessing splenic enlargement on CT by unidimensional measurement changes in patients with colorectal liver metastases (2015) (8)
- Is neoadjuvant (neoadj) treatment necessary prior to liver resection in patients with resectable liver metastases (mets) from colorectal carcinoma (CRC) treated with post-resection hepatic arterial infusion (HAI) plus systemic (SYS) chemotherapy (2007) (8)
- Local Control and Survival After Induction Chemotherapy and Ablative Radiation Versus Resection for Pancreatic Ductal Adenocarcinoma With Vascular Involvement (2021) (8)
- Liver and Bile Duct Cancer (2020) (8)
- Synoptic operative reporting for laparoscopic cholecystectomy and pancreaticoduodenectomy: A multi institutional pilot study evaluating completeness and surgeon perceptions. (2018) (8)
- Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy (2020) (7)
- Biopsy and Margins Optimize Outcomes after Thermal Ablation of Colorectal Liver Metastases (2022) (7)
- Genomic stratification beyond Ras/B‐Raf in colorectal liver metastasis patients treated with hepatic arterial infusion (2019) (7)
- Recurrent invasive intraductal papillary mucinous carcinoma of the pancreas mimicking pott disease: review of the literature. (2006) (7)
- Systemic Therapy for Patients with Resectable Hepatic Colorectal Metastases: Improving Patient Selection (2013) (7)
- Prognostic Significance of the Highest Peripancreatic Lymph Node in Biliary Tract Adenocarcinoma (2014) (7)
- Locoregional Therapy for Hepatocellular Carcinoma with and without Extrahepatic Spread. (2015) (7)
- Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers (2012) (7)
- Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? (2022) (7)
- Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas (2017) (7)
- Defining the risk of liver failure after minor hepatectomy: a NSQIP analysis of 7029 patients. (2020) (7)
- Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms (2020) (7)
- Training Paradigms in Hepato-Pancreatico-Biliary Surgery: an Overview of the Different Fellowship Pathways (2021) (7)
- Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. (2012) (7)
- Liver angiomyolipomas: a clinical, radiologic, and pathologic analysis of 22 patients from a single center. (2011) (7)
- Intra-arterial Chemotherapy for Liver Tumors (2007) (6)
- A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC). (2018) (6)
- Current role of therapeutic laparoscopy and thoracoscopy in the management of malignancy: a review of trends from a tertiary care cancer center. (2008) (6)
- Symptomatic Perihepatic Fluid Collections After Hepatic Resection in the Modern Era (2016) (6)
- Association of preoperative biliary drainage technique with postoperative outcomes among patients with resectable hepatobiliary malignancy. (2020) (6)
- Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases (2020) (6)
- Cytokine gene therapy for human tumors. (1998) (6)
- Hepatocellular adenoma among adult survivors of childhood and young adult cancer (2017) (6)
- Surgical salvage of recurrence after resection of colorectal liver metastases: incidence and outcomes. (2017) (6)
- An update on randomized clinical trials in advanced and metastatic colorectal carcinoma. (2010) (6)
- Hepatic arterial infusion chemotherapy for metastases from colorectal cancer: is it really the end of an era? (2008) (6)
- The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases. (2019) (6)
- Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas (2017) (6)
- Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy (2020) (6)
- Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases (2018) (6)
- Phase I trial of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (DEX) in combination with systemic oxaliplatin (OXAL), fluorouracil (FU) + leucovorin (LV) after resection of hepatic metastases from colorectal cancer (2005) (6)
- Hepatic steatosis is associated with increased complications following major liver resection for cancer but does not impact survival (2003) (6)
- An outlook on precision surgery. (2017) (6)
- What Is Riskier for the Patient with an Asymptomatic Large Hepatic Hemangioma: Observation or the Surgeon? (2013) (6)
- Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation. (2013) (6)
- Getting Chemotherapy Directly to the Liver: The Historical Evolution of Hepatic Artery Chemotherapy. (2020) (5)
- Hepatic resection for metastatic breast cancer: an exercise in selection bias. (2016) (5)
- Expression of the c-met and HGF in resected hepatocellular carcinoma (rHCC): Correlation with clinicopathological features (CP) and overall survival (OS) (2008) (5)
- Metastatic Colorectal Cancer to the Liver: Involve the Surgeon Early and Often (2015) (5)
- Cancer of the bile ducts: Extrahepatic biliary tumors (2012) (5)
- Liver resection after hepatic arterial infusion (HAI) plus systemic oxaliplatin (Oxal) combinations in pretreated patients with extensive unresectable colorectal liver metastases. (2004) (5)
- Positive Margins After Resection of Metastatic Colorectal Cancer in the Liver: Back to the Drawing Board? (2017) (5)
- Malignant progression in intraductal papillary mucinous neoplasms of the pancreas: Results of 157 patients selected for radiographic surveillance. (2012) (5)
- Can physician gestalt predict survival in patients with resectable pancreatic adenocarcinoma? (2018) (5)
- Cefoxitin versus piperacillin–tazobactam as surgical antibiotic prophylaxis in patients undergoing pancreatoduodenectomy: protocol for a randomised controlled trial (2021) (5)
- Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients (2018) (5)
- Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases (2019) (5)
- Surgical Management of Colorectal Cancer Liver Metastases. (2021) (5)
- Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases. (2015) (4)
- Timing of Complication and Failure to Rescue after Hepatectomy: Single-Institution Analysis of 28-Years of Hepatic Surgery. (2021) (4)
- Intraductal papillary neoplasm of the bile duct (IPNB): A biliary equivalent to IPMN of the pancreas? (2011) (4)
- Survival after resection of liver metastases from colorectal cancer with poor clinical risk factors using adjuvant systemic plus hepatic arterial therapy (2008) (4)
- Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy. (2017) (4)
- Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional study. (2020) (4)
- Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care (2021) (4)
- The Interplay of Primary Tumor Location and KRAS Mutation Status in Patients with Synchronous Colorectal Cancer Liver Metastases: Current Data and Unanswered Questions (2020) (4)
- Consensus conference on intrahepatic cholangiocarcinoma. (2015) (3)
- Biliary-Enteric Anastomosis (2007) (3)
- Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. (2020) (3)
- Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions (2014) (3)
- Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla (2014) (3)
- Are patients with multiple hepatic metastases from colorectal cancer candidates for surgery? (2007) (3)
- Lending a hand for laparoscopic distal pancreatectomy: the optimal approach? (2019) (3)
- Demystifying BRAF Mutation Status in Colorectal Liver Metastases: A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions. (2022) (3)
- Levels of Evidence in Medical Research: "Bigger Is Not Always Better". (2017) (3)
- Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery (2020) (3)
- Survival after resection plus intra-operative radiofrequency ablation (IRFA) to treat colorectal liver metastases (CLM): Results of an international collaborative study. (2013) (3)
- Prospective Phase II Trial of Combination Hepatic Artery and Systemic Chemotherapy for Unresectable Colorectal Liver Metastases: Long-Term Results and Curative Potential (2016) (3)
- Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver‐related mortality (2020) (3)
- Radiofrequency-assisted Hepatectomy May Induce Severe Postoperative Liver Damage (2007) (3)
- Hepatic arterial infusion (HAI) therapy in patients with unresectable primary liver cancer: Use of dynamic contrast enhanced MRI to evaluate response (2005) (3)
- Predictors of a true complete response in colorectal liver metastases that disappear radiographically following chemotherapy (2007) (3)
- Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy (2022) (3)
- Right versus left: Impact of primary location on survival and cure in patients undergoing hepatic resection for metastatic colon cancer. (2017) (3)
- Early liver metastases after "failure" of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy? (2020) (3)
- Multiinstitutional Validation Study of Cyst Fluid Protein Biomarkers in Patients With Cystic Lesions of the Pancreas (2021) (2)
- Chapter 29 – Bile duct exploration and biliary-enteric anastomosis (2012) (2)
- Hepatic artery therapies for unresectable colorectal liver metastases: Pooled survival analysis of 968 patients from TACE, yttrium-90, and HAI studies. (2017) (2)
- Embolization with microspheres alone for hepatocellular carcinoma with portal vein tumor: analysis of outcome and liver function at disease progression. (2020) (2)
- Use of T-cell proliferation to predict survival and recurrence in patients with resected colorectal liver metastases. (2010) (2)
- Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence–Based Model (2021) (2)
- Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention. (2016) (2)
- Complications of Intra-Arterial Regional Liver Therapy (2019) (2)
- Genomic Stratification of Resectable Colorectal Liver Metastasis Patients and Implications for Adjuvant Therapy and Survival (2021) (2)
- T1583 A Matched Case-Control Study of Preoperative Biliary Drainage (PDB) in Patients with Pancreatic Adenocarcinoma: Routine PBD Is Not Justified (2009) (2)
- Chemotherapy-Associated Hepatotoxicity and Hepatic Resection for Metastatic Colorectal Cancer (2014) (2)
- Machine learning radiomics can predict early liver recurrence after resection of intrahepatic cholangiocarcinoma. (2022) (2)
- Hepatic resection planning in the modern era: in reply to Mise and colleagues. (2014) (2)
- Association of KRAS mutation with worse recurrence-free survival and site of metastatic progression after resection of hepatic colorectal metastases. (2013) (2)
- Percutaneous liver venous deprivation: outcomes in heavily pretreated metastatic colorectal cancer patients. (2021) (2)
- Response rates to hepatic arterial infusion (HAI) pump therapy in patients with metastatic colorectal cancer liver metastases (mCRC LM) after progression on all standard chemotherapies. (2014) (2)
- Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network. (2022) (2)
- Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement (2021) (2)
- Surgical management of biliary malignancy. (2020) (2)
- Improvement in long-term survival in patients with metastatic colorectal cancer (CRC) after liver resection with modern chemotherapy and hepatic arterial infusion (HAI). (2015) (2)
- Invasive central venous monitoring during hepatic resection: unnecessary for most patients. (2019) (2)
- Mutational profiling of resected intrahepatic cholangiocarcinoma. (2017) (2)
- 148 Biliary Self Expandable Metal Stents Do Not Increase Overall Complications in Patients Undergoing Pancreaticoduodenectomy (2012) (2)
- A combined radiomics and cyst fluid inflammatory markers model to predict preoperative risk in pancreatic cystic lesions (2020) (1)
- Use of detailed pathologic characteristics of the primary colorectal tumor to predict outcome after hepatectomy for metastases. (2012) (1)
- Staging Stage IV Colorectal Cancer (2013) (1)
- Endoscopic versus percutaneous drainage of post-operative fluid collection following pancreatic resection (2017) (1)
- Change in circulating tumor DNA after hepatic resection for metastatic colorectal cancer (2018) (1)
- Postoperative mortality after liver resection for perihilar cholangiocarcinoma: Importance of biliary drainage of the future liver remnant and development of a risk score (2016) (1)
- Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinoma (2022) (1)
- Abstract 579: Immune features and neoantigen recognition in mismatch repair-proficient colorectal cancer liver metastases (2019) (1)
- Alterations in Somatic Driver Genes Are Associated with Response to Neoadjuvant FOLFIRINOX in Patients with Localized Pancreatic Ductal Adenocarcinoma. (2022) (1)
- Survival in Patients with Intrahepatic Cholangiocarcinoma and Positive Lymph Nodes: No Benefit of Resection over Hepatic Arterial Infusion Chemotherapy (2020) (1)
- Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1H MRS study (2014) (1)
- Two-stage hepatectomy for colorectal liver metastases: A multi-institutional retrospective review. (2017) (1)
- Triple rendezvous using percutaneous, endoscopic, and real-time CT to safely reanastomose bile duct transection following liver resection (2014) (1)
- Segmental vs. Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm: Examination of Main Pancreatic Duct Morphology and Implications for Malignancy Risk and Extent of Surgical Resection. (2022) (1)
- ASO Author Reflections: Primary Tumor Location and Long-Term Survival After Hepatic Resection for Metastatic Colon Cancer (2018) (1)
- Laparoscopic partial hepatectomy (2005) (1)
- Dynamic contrast enhanced MRI (DCE-MRI) to measure antiangiogenic therapy and predict treatment response in primary liver cancer (PLC). (2010) (1)
- Chapter 49 – Cancer of the gallbladder (2012) (1)
- Metastatic Liver Tumors: The Path to Disease-Free Survival. (2021) (1)
- The Ligamentum Teres Approach and Other Approaches to the Intrahepatic Ducts for Palliative Bypass (2007) (1)
- Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial Embolization: A Retrospective Study on Patterns, Treatments, and Prognoses (2022) (1)
- QS224. Genome Wide Analysis and Clinical Correlation of Chromosomal and Transcriptional Mutations in Cancers of the Biliary Tract (2008) (1)
- Percutaneous microwave ablation for colorectal cancer liver metastasis: initial results (2014) (1)
- Intraoperative Injury to Hepatic Arterial Structures (2015) (1)
- Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients (2020) (1)
- Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial. (2023) (1)
- Local Therapy for Oligoprogression or Consolidation in High Mutational Burden Stage 4 Colorectal Cancer Treated With PD-1 or PD-L1 Blockade (2022) (1)
- Influence of KRAS mutation on recurrence patterns in patients undergoing hepatic resection of colorectal metastases. (2013) (1)
- Surgical therapy and survival prospects in hilar cholangiocarcinoma (2003) (1)
- Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal Adenocarcinoma (2021) (1)
- Abstract 2444: The use of CT radiomics to predict immune infiltrate in pancreatic ductal adenocarcinoma (2019) (1)
- Hepatic Artery Infusion Therapy for Colorectal Cancer Liver Metastases (2018) (1)
- Clinical/pathologic features and survival of patients with fibrolamellar-hepatocellular carcinoma (FLL-HCC): Data from the Fibrolamellar-Hepatocellular (FLL-HCC) Consortium. (2011) (1)
- Is conversion to resection possible with hepatic arterial infusion (HAI) and systemic (SYS) even in previously treated patients (pts) with unresectable colorectal liver metastases (UnCLM) (2012) (1)
- Infiltrating neutrophils and malignant progression in intraductal papillary mucinous neoplasms (IPMN): An opportunity for identification of high-risk disease. (2014) (1)
- Registry‐based randomized clinical trials in surgery: Working with ACS‐NSQIP and the AHPBA to conduct pragmatic trials (2021) (1)
- A Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Therapy With or Without Panitumumab After Hepatic Resection of KRAS Wild-type Colorectal Cancer (2021) (1)
- Association of genomic profiles and survival in early onset and screening‐age colorectal cancer patients with liver metastases resected over 15 years (2022) (1)
- Transient ischemic-reperfusion injury of the liver promotes tumor growth by modulation of arginine metabolism and suppresion of immune function (1998) (1)
- Effect of perioperative complications on recurrence and survival after resection of hepatic colorectal metastases: Analysis of data from a randomized controlled trial. (2012) (1)
- Hepatic arterial infusion (HAI) chemotherapy via the medtronic pump-assessing dose delivery, response rates and toxicity. (2020) (1)
- Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma (2021) (1)
- A Multi-Institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-Grade Dysplasia in Intraductal Papillary Mucinous Neoplasms (2016) (1)
- Prognostic Markers and Staging Systems for Patients with Colorectal Liver Metastases (2011) (1)
- Laparoscopic liver resection. (2012) (1)
- Patterns of failure in patients with resectable synchronous liver metastases from rectal cancer (SLMRC): An analysis of the outcomes with and without pelvic radiotherapy. (2011) (1)
- FOLFIRINOX induction therapy for stage III pancreatic adenocarcinoma (2014) (1)
- 80 – Liver and Bile Duct Cancer (2014) (1)
- Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results? (2011) (1)
- Modern Locoregional Treatment of Colorectal Cancer Liver Metastases (2016) (1)
- Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastases (2020) (1)
- Hepatic Artery Infusion Pumps (2022) (1)
- Hepatocellular carcinoma in patients with no identifiable risk factors. (2019) (1)
- Adjuvant hepatic arterial infusion chemotherapy is associated with superior survival after resection of colorectal liver metastases: A propensity score analysis of 2368 patients (2016) (0)
- ASO Author Reflections: Upfront Surgery for Resectable Colorectal Liver Metastases: Biology is (Still) King (2023) (0)
- Adequate lymph node assessment for extrahepatic bile duct cancer: Do the data support the current AJCC recommendations? (2009) (0)
- Spectrum and outcome of repair of benign biliary strictures (2003) (0)
- Colorectal Cancer: Metastatic (Palliation) (2007) (0)
- Regional differences in gallbladder cancer pathogenesis: Insights from a comparison of tumor mutations (2018) (0)
- Poor prognosis in patients with resectable KRAS-MUT colorectal liver metastases is improved by adjuvant hepatic arterial infusion chemotherapy. (2017) (0)
- Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases; results of a safety and feasibility study in the Netherlands (2020) (0)
- A multicentre analysis on the impact of primary tumour location in patients undergoing surgery for colorectal liver metastasis. (2019) (0)
- 916 Tumor Grade, Not Extent of Resection, Is Associated With Recurrence-Free Survival in Patients With Duodenal Neuroendocrine Tumors (2013) (0)
- Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases; a phase II trial (2020) (0)
- Circulating CD133: A Promising Biomarker, but What Are We Measuring? (2012) (0)
- Longitudinal follow-up of a prospective phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma reveals distinct patterns of survivorship (2019) (0)
- 肝部分切除术理想的手术切口:Mercedes型切口远期并发症较扩大右肋缘下切口增加 (2006) (0)
- 913 Pharmacologic Prophylaxis, Postoperative INR, and Risk of Venous Thromboembolism After Hepatectomy (2013) (0)
- Issue Information ‐ TOC (2016) (0)
- Symptomatic perihepatic collections after hepatic resection in the modern era (2014) (0)
- Health-related quality of life (HRQoL) following pancreatic resection in RCT of pasireotide. (2014) (0)
- Percutaneous radiofrequency ablation of colorectal cancer liver Metastases: Factors Affecting Outcomes—A 10-year Experience at a Single Center 1 (2016) (0)
- Long-termOutcomes Following Tumor Ablation for Treatment of Bilateral Colorectal LiverMetastases (2013) (0)
- Multidisciplinary, perioperative care bundle decreases surgical site infection in patients undergoing synchronous colorectal/liver resection (2018) (0)
- Minimally invasive versus open segment 7 and 8 hepatic resection: a propensity score-matched comparison (2017) (0)
- Use of CXCR4 as a prognostic marker for disease-specific survival and pattern of recurrence following resection of hepatic colorectal metastases. (2009) (0)
- Resection of parenchymal liver metastases in patients with uterine malignancies (2019) (0)
- Is PET scan conversion from positive to negative a prognostic indicator for patients receiving therapy for unresectable liver metastases from colorectal carcinoma (CRC)? (2011) (0)
- Conversion to complete surgical treatment using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer. (2012) (0)
- Sa1487 Direct Percutaneous Endoscopic Jejunostomy for Management of Severe Delayed Gastric Emptying Following Pancreatoduodenectomy (2015) (0)
- Hepatic adenoma among adult survivors of childhood cancer. (2016) (0)
- Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival. (2023) (0)
- A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy (2022) (0)
- Role of biliary CEACAM6 as a biomarker for cholangiocarcinoma. (2013) (0)
- Hepatic arterial infusion for unresectable intrahepatic cholangiocarcinoma: An update on survival from two prospective clinical trials. (2013) (0)
- 488 Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection vs. Observation (2015) (0)
- – BONE AND SOFT TISSUE SARCOMAS Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor (2019) (0)
- An analysis of the extent of hepatectomy for adenocarcinoma of the gallbladder (2005) (0)
- Concordance in oncogenic alterations between primary and recurrent/metastatic cholangiocarcinoma pairs using targeted next-generation sequencing. (2023) (0)
- utcomes after Resection of Synchronous r Metachronous Hepatic and Pulmonary olorectal Metastases (2007) (0)
- Radioembolization as a salvage therapy for heavily pre-treated patients with colorectal cancer liver metastases: factors affecting outcomes (2016) (0)
- Re : Interferon : The Magic Bullet to Prevent Hepatocellular Carcinoma Recurrence After Resection ? (0)
- Immediate post-thermal ablation biopsy of colorectal liver metastases to predict oncologic outcomes. (2020) (0)
- Reply to H. Zhang et al. (2013) (0)
- AHPBA Webinar about Covid-19: lessons learned responding to a pandemic (2020) (0)
- Evaluation of the Implementation of Enhanced Recovery after Surgery Pathways in Pancreatic Surgery (2022) (0)
- Microwave Ablation (MWA) for the Treatment of a Solitary, Chemorefractory Testicular Cancer Liver Metastasis (2015) (0)
- M1501 Polypoid Lesions of Gallbladder: Diagnosis and Follow-Up (2008) (0)
- 1325 Regulation of Tissue factor (TF) in colorectal cancer: association with KRAS (2009) (0)
- The management of small asymptomatic pancreatic neuroendocrine tumors: A matched case-control study. (2015) (0)
- Alterations in Driver Genes Are Associated with Response to Neoadjuvant Folfirinox in Patients with Nonmetastatic Pancreatic Ductal Adenocarcinoma (2021) (0)
- Behind the cyst: predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) by quantitative image analysis (2017) (0)
- Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients (2018) (0)
- Meeting the biologic challenge of colorectal metastases (2012) (0)
- Gene expression profiles to predict outcome following liver resection in patients with metastasis of colorectal cancer. (2010) (0)
- Abstract A040: CT Radiomics to predict early recurrence of margin-negative resectable pancreatic ductal adenocarcinoma (2022) (0)
- Hospital variation in use of prophylactic drains following hepatectomy. (2020) (0)
- Computerized Diagnosis of Liver Tumors From CT Scans Using a Deep Neural Network Approach (2023) (0)
- Intra-Arterial Therapy for Unresectable Colorectal Liver Metastases: Which and When? A Commentary on "Intra-Arterial Therapy for Unresectable Colorectal Liver Metastases: A Meta-Analysis". (2021) (0)
- A Prospective Cohort Study of a Perioperative Bundle to Reduce Surgical Site Infection following Pancreaticoduodenectomy (2021) (0)
- Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC). (2011) (0)
- Su1530 Robotic Hepatic Artery Infusion Pump Placement (2016) (0)
- Association of adjuvant hepatic artery infusion chemotherapy after resection of colorectal liver metastases with improved survival in patients with both right- and left-sided primary tumors. (2018) (0)
- Improved mortality after pancreatectomy in the modern era (2018) (0)
- Outcomes after pancreatectomy with routine usage of pasireotide (2018) (0)
- W1668 The use of Intraoperative Ablation Extends the Limits of Potentially Curative Treatment for Recurrent Colorectal Liver Metastases (2010) (0)
- AB005. S005. A multiinstitutional postoperative nomogram for disease recurrence following resection of localized G1/G2 pancreatic neuroendocrine tumors (2018) (0)
- Intra-Arterial Chemotherapy (2017) (0)
- Pathology remains the most important predictor of long-term survival using a modern prognostic nomogram for resected pancreatic ductal adenocarcinoma (2019) (0)
- Cell Cycle Regulatory Protein Expression in Biliary Tract Adenocarcinoma (2005) (0)
- Timing of perioperative chemotherapy in the surgical treatment of colorectal liver metastases: a propensity score matched analysis (2020) (0)
- Hepatobiliary Cancers Clinical Practice Guidelines in OncologyTM (2009) (0)
- Incidence and risk factors for biliary sclerosis following adjuvant hepatic arterial infusion with floxuridine after hepatectomy for metastatic colorectal cancer. (2010) (0)
- ASO Author Reflections: Ras-p53 Cooperativity Predicts Recurrence Patterns After Resection of Colorectal Liver Metastases with Adjuvant Local and Systemic Chemotherapy (2022) (0)
- ASO Author Reflections: Complex General Surgical Oncology Fellowships: What Are Programs Looking For? (2019) (0)
- ASO Visual Abstract: Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement (2022) (0)
- Phase II trial of maximal ablative irradiation because of encasement (MAIBE) for patients with potentially resectable locally advanced pancreatic cancer. (2023) (0)
- Patterns of recurrence and peri-operative predictors of liver metastasis after pancreatic cancer resection (2018) (0)
- Outcomes following transarterial embolization for hepatocellular carcinoma with complete radiologic response (2018) (0)
- Comparison of Clinicopathological Characteristics, Protein Expression Profiling and Outcomes in Eastern and Western Patients with Hepatocellular Carcinoma (2005) (0)
- Differentiation of mucinous cysts and simple cysts of the liver using preoperative imaging (2022) (0)
- ASO Author Reflections: Characterizing the Impact of RAS Mutation Location on Outcomes for Colorectal Liver Metastases (2020) (0)
- Genetic heterogeneity of intrahepatic cholangiocarcinoma: Implications for outcome. (2023) (0)
- Gallbladder Cancer with Common Bile Duct Invasion (2017) (0)
- 630 Laparoscopic Versus Open Liver Resection: A Matched-Pair Case Control Study (2009) (0)
- 1028 Management of Symptomatic Intraabdominal Collections After 672 Hepatic Resections (2009) (0)
- Role of Hepatic Artery Infusion Pump Chemotherapy for Unresectable Colorectal Cancer Liver Metastases (2019) (0)
- 1031 Natural History of Patients Followed Radiographically With Mucinous Cystic Neoplasms of the Pancreas (2016) (0)
- Issue Information ‐ TOC (2018) (0)
- A retrospective study of hepatic arterial infusion (HAI) FUDR/Dex and mitomycin C (MMC) for chemotherapy refractory unresectable intrahepatic cholangiocarcinomas (ICC). (2019) (0)
- Proteomic evaluation of biliary exosomes implicates exportin7 in the pathogenesis of extrahepatic cholangiocarcinoma (2017) (0)
- Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy. (2022) (0)
- Patient Variability in Intraoperative Ultrasonographic Characteristics of Colorectal Liver Metastases—Invited Critique (2008) (0)
- Chapter 85B – Cryoablation for liver tumors (2012) (0)
- Safety and Feasibility of Hepatic Artery Infusion Pump Chemotherapy for Unresectable Colorectal Liver Metastases: A Multicenter, Retrospective Cohort Study (2019) (0)
- ASO Visual Abstract: Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy (2022) (0)
- MHC Class II Expression Influences the Composition and Distribution of Immune Cells in the Metastatic Colorectal Cancer Microenvironment (2022) (0)
- Rates and Treatment Patterns of Gallbladder-Related Emergency General Surgery Conditions in the Cancer Population (2022) (0)
- Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage. (2023) (0)
- Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al. (2017) (0)
- Adjuvant modified FOLFIRINOX (mFFX) for resected pancreatic cancer (PDAC): Real world outcomes (RWO). (2023) (0)
- Chapter 98D – Cryotherapy and ethanol injection (2017) (0)
- Chapter 28 – Quality of life and hepatobiliary tumors (2017) (0)
- In Brief (1995) (0)
- Comment on Hasselgren K, et al. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021;273(3):442-448. (2021) (0)
- Recurrence Patterns after Irreversible Electroporation for Hepatic Metastases (2016) (0)
- Significance of CEACAM6 expression in biliary tract carcinoma. (2012) (0)
- Advances in the management of liver and biliary tumors (2022) (0)
- A palpable pancreatic duct. (2017) (0)
- Management of Metastatic Liver Tumors (2021) (0)
- Chromosomal instability mediates immune exclusion and response to cytotoxic chemotherapy in colorectal liver metastases (2021) (0)
- Extraordinary survivorship after colorectal liver metastasis resection to identify a distinct molecular profile associated with survival in an independent cohort of 965 patients. (2017) (0)
- Quality of life in RCT of pasireotide to reduce pancreatic complications following resection. (2015) (0)
- ASO Author Reflections: How Immunotherapy Could Change the Management of Responsive Solid Tumors (2022) (0)
- Non-alcoholic fatty liver disease is an independent predictor of recurrence after resection of colorectal liver metastases (2019) (0)
- Randomized phase II trial of adjuvant hepatic arterial infusion (HAI) + systemic FOLFIRI +/- panitumumab (Pmab) in patients with resected RAS wild type colorectal cancer hepatic metastases (CRLM). (2019) (0)
- A 46-Year-Old Asian Woman With Liver Mass. (2015) (0)
- Trans-arterial embolization for hepatocellular carcinoma: doxorubicin is not necessary (2016) (0)
- The Influence of Patient Preference on Surgeons' Treatment Recommendations in the Management of Intraductal Papillary Mucinous Neoplasms. (2023) (0)
- ASO Visual Abstract: Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial embolization: A Retrospective Study on Patterns, Treatments, and Prognosis (2022) (0)
- Liver resection. State of the art. (2006) (0)
- Identification of potentially actionable molecular alterations in advanced hepatocellular carcinoma (HCC). (2016) (0)
- Abstract No. 107: Radiofrequency ablation of recurrent colorectal cancer hepatic metastases after hepatectomy (2010) (0)
- Image of the month. Papillary low-grade neuroendocrine tumor of the pancreas with pancreatic duct dilation. (2005) (0)
- ASO Visual Abstract: Recurrence After Resection of Pancreatic Cancer – Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? (2022) (0)
- ASO Visual Abstract: A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases (2023) (0)
- A novel tool to predict nodal metastasis in small pancreatic neuroendocrine tumors: A multicenter study. (2022) (0)
- Colorectal cancer: a multifaceted disease. (2019) (0)
- Risk Perceptions and Risk Thresholds Among Surgeons in the Management of Intraductal Papillary Mucinous Neoplasms (2023) (0)
- Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma. (2023) (0)
- CT radiomics to predict early hepatic recurrence after resection for intrahepatic cholangiocarcinoma (2022) (0)
This paper list is powered by the following services: